IL-33 induced gene expression in activated Th2 effector cells is dependent on IL-1RL1 haplotype and asthma status
Open Access
- 6 June 2024
- journal article
- letter
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 63 (6) , 2400005
Abstract
Asthma is a heterogeneous respiratory disease caused by the interaction between environmental and genetic factors [1]. The IL-33 and IL-1RL1 genes are strongly associated with childhood-onset and type-2 high asthma, and the asthma risk alleles amplify interleukin (IL)-33 pathway activity [2]. Environmental factors, such as allergens and viral infections, trigger bronchial epithelial cells to release IL-33, which can activate signalling by binding to the IL-1RL1/IL-1RAcP receptor complex [3], and contribute to hyper-responsiveness, remodelling and chronic type 2 inflammation of the airways [4].Keywords
Funding Information
- GlaxoSmithKline foundation
- Lung Foundation Netherlands (3.2.09.081JU)
This publication has 12 references indexed in Scilit:
- An integrated cell atlas of the lung in health and diseaseNature Medicine, 2023
- AsthmaThe Lancet, 2023
- The central role of IL-33/IL-1RL1 pathway in asthma: From pathogenesis to interventionPharmacology & Therapeutics, 2021
- Phenotypic and functional translation of IL33 genetics in asthmaJournal of Allergy and Clinical Immunology, 2021
- Single-cell transcriptomic analysis of allergen-specific T cells in allergy and asthmaScience Immunology, 2020
- Differential DNA methylation in bronchial biopsies between persistent asthma and asthma in remissionEuropean Respiratory Journal, 2019
- A cellular census of human lungs identifies novel cell states in health and in asthmaNature Medicine, 2019
- Interleukin‐33 (IL‐33): A nuclear cytokine from the IL‐1 familyImmunological Reviews, 2017
- T-helper cell type 2 (Th2) and non-Th2 molecular phenotypes of asthma using sputum transcriptomics in U-BIOPREDEuropean Respiratory Journal, 2017
- IL-33: an alarmin cytokine with crucial roles in innate immunity, inflammation and allergyCurrent Opinion in Immunology, 2014